Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.94750674 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55081832 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44904076 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44904076 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44904076 |
6 | modulation by symbiont of host immune response (GO:0052553) | 5.44904076 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44904076 |
8 | modulation by symbiont of host defense response (GO:0052031) | 5.44904076 |
9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16654618 |
10 | * regulation of B cell receptor signaling pathway (GO:0050855) | 5.14129688 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.10229883 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.86885997 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.86885997 |
14 | immunoglobulin mediated immune response (GO:0016064) | 4.43499402 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39530499 |
16 | negative regulation of cell killing (GO:0031342) | 4.39530499 |
17 | B cell receptor signaling pathway (GO:0050853) | 4.38017625 |
18 | positive regulation of interferon-alpha production (GO:0032727) | 4.34797770 |
19 | positive thymic T cell selection (GO:0045059) | 4.33401543 |
20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.32568189 |
21 | negative thymic T cell selection (GO:0045060) | 4.31599803 |
22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.30695084 |
23 | negative T cell selection (GO:0043383) | 4.29492405 |
24 | negative regulation of interleukin-12 production (GO:0032695) | 4.21805309 |
25 | regulation of interferon-alpha production (GO:0032647) | 4.19632465 |
26 | neutrophil activation involved in immune response (GO:0002283) | 4.16460370 |
27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11091533 |
28 | T cell migration (GO:0072678) | 4.04801030 |
29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98642337 |
30 | macrophage activation involved in immune response (GO:0002281) | 3.91064051 |
31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90847358 |
32 | tolerance induction (GO:0002507) | 3.86374832 |
33 | leukocyte aggregation (GO:0070486) | 3.81467668 |
34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.74421690 |
35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.74292000 |
36 | NIK/NF-kappaB signaling (GO:0038061) | 3.69609791 |
37 | mast cell activation (GO:0045576) | 3.63003260 |
38 | regulation of B cell differentiation (GO:0045577) | 3.60992554 |
39 | positive regulation of B cell differentiation (GO:0045579) | 3.60291800 |
40 | thymic T cell selection (GO:0045061) | 3.60051559 |
41 | cellular response to interleukin-15 (GO:0071350) | 3.55098581 |
42 | myeloid cell activation involved in immune response (GO:0002275) | 3.55023373 |
43 | response to interleukin-15 (GO:0070672) | 3.52871696 |
44 | interferon-gamma production (GO:0032609) | 3.51587339 |
45 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.51052646 |
46 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50176245 |
47 | B cell mediated immunity (GO:0019724) | 3.50089446 |
48 | respiratory burst (GO:0045730) | 3.49400775 |
49 | positive T cell selection (GO:0043368) | 3.45265945 |
50 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42847729 |
51 | cellular response to zinc ion (GO:0071294) | 3.42496133 |
52 | regulation of antigen processing and presentation (GO:0002577) | 3.41699527 |
53 | pinocytosis (GO:0006907) | 3.40574236 |
54 | cytidine deamination (GO:0009972) | 3.39234787 |
55 | cytidine metabolic process (GO:0046087) | 3.39234787 |
56 | cytidine catabolic process (GO:0006216) | 3.39234787 |
57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38152356 |
58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36772505 |
59 | response to peptidoglycan (GO:0032494) | 3.34084041 |
60 | response to host immune response (GO:0052572) | 3.33594851 |
61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33594851 |
62 | type I interferon signaling pathway (GO:0060337) | 3.33119148 |
63 | cellular response to type I interferon (GO:0071357) | 3.33119148 |
64 | microglial cell activation (GO:0001774) | 3.32869121 |
65 | response to type I interferon (GO:0034340) | 3.32309919 |
66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30588698 |
67 | T cell selection (GO:0045058) | 3.25093279 |
68 | defense response to protozoan (GO:0042832) | 3.21010547 |
69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.20816240 |
70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20424341 |
71 | cellular extravasation (GO:0045123) | 3.20161779 |
72 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18613736 |
73 | regulation of tolerance induction (GO:0002643) | 3.18031793 |
74 | regulation of T cell tolerance induction (GO:0002664) | 3.17679845 |
75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14532015 |
76 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14532015 |
77 | T cell costimulation (GO:0031295) | 3.12608090 |
78 | response to muramyl dipeptide (GO:0032495) | 3.10379262 |
79 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.09318317 |
80 | neutrophil activation (GO:0042119) | 3.09175017 |
81 | positive regulation of interferon-beta production (GO:0032728) | 3.08536324 |
82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08533662 |
83 | detection of other organism (GO:0098543) | 3.08126127 |
84 | lymphocyte costimulation (GO:0031294) | 3.07850059 |
85 | granulocyte activation (GO:0036230) | 3.07347917 |
86 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.06278074 |
87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06210947 |
88 | response to host (GO:0075136) | 3.06210947 |
89 | response to host defenses (GO:0052200) | 3.06210947 |
90 | positive regulation of mast cell activation (GO:0033005) | 3.05866816 |
91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05750054 |
92 | myeloid dendritic cell activation (GO:0001773) | 3.04681046 |
93 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.04670698 |
94 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.04391195 |
95 | positive regulation of macrophage differentiation (GO:0045651) | 3.04315631 |
96 | positive regulation of isotype switching (GO:0045830) | 3.04168887 |
97 | detection of bacterium (GO:0016045) | 3.03725904 |
98 | positive regulation of interleukin-2 production (GO:0032743) | 3.03266554 |
99 | lymphocyte chemotaxis (GO:0048247) | 3.02023354 |
100 | germinal center formation (GO:0002467) | 3.00838483 |
101 | natural killer cell mediated immunity (GO:0002228) | 2.98428635 |
102 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98428635 |
103 | lymphocyte migration (GO:0072676) | 2.97843565 |
104 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.97586122 |
105 | response to protozoan (GO:0001562) | 2.95311107 |
106 | sequestering of actin monomers (GO:0042989) | 2.92976277 |
107 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.92489426 |
108 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91959850 |
109 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.91564695 |
110 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91564695 |
111 | * negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.91314020 |
112 | cellular response to interferon-gamma (GO:0071346) | 2.90384336 |
113 | mature B cell differentiation (GO:0002335) | 2.90186695 |
114 | regulation of regulatory T cell differentiation (GO:0045589) | 2.89726955 |
115 | actin nucleation (GO:0045010) | 2.89533094 |
116 | T cell receptor signaling pathway (GO:0050852) | 2.89180555 |
117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88004535 |
118 | myeloid dendritic cell differentiation (GO:0043011) | 2.87597921 |
119 | B cell homeostasis (GO:0001782) | 2.87331394 |
120 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.87240352 |
121 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86885841 |
122 | regulation of response to interferon-gamma (GO:0060330) | 2.86525788 |
123 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84580309 |
124 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83931755 |
125 | myeloid leukocyte activation (GO:0002274) | 2.83644716 |
126 | macrophage activation (GO:0042116) | 2.83629261 |
127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81547535 |
128 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.80741688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.06235098 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.42794006 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.35860887 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.73992117 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.11069874 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.03538782 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.79543488 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44743823 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40312511 |
10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.36542780 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23110883 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.17609068 |
13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15245066 |
14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99579845 |
15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87111702 |
16 | MYB_26560356_Chip-Seq_TH2_Human | 2.58047547 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53774829 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 2.47566946 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47389101 |
20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44607005 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.40472437 |
22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40036767 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.34938574 |
24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23064936 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19961058 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19489787 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18467849 |
28 | MYB_26560356_Chip-Seq_TH1_Human | 2.17077178 |
29 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16942277 |
30 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16352933 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14563459 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11604785 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06615022 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94438198 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93920741 |
36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85306253 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84537071 |
38 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82694124 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79612034 |
40 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76067366 |
41 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70003255 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68865604 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64963126 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63393884 |
45 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62619134 |
46 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58158258 |
47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56362562 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.55044173 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46319160 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43581100 |
51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43214096 |
52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42396625 |
53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41787887 |
54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38880074 |
55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31502161 |
56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27509224 |
57 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25461848 |
58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25022243 |
59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22838841 |
60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22169272 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18787979 |
62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18642666 |
63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16774689 |
64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15574271 |
65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13088528 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12743413 |
67 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11924877 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08460339 |
69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07395926 |
70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04088008 |
71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03946187 |
72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03194344 |
73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02228243 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02069739 |
75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00513312 |
76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99061464 |
77 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98189616 |
78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98147194 |
79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97337343 |
80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96810481 |
81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96682646 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95140088 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95002721 |
84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94803998 |
85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91105047 |
86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90021853 |
87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85579395 |
88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84379504 |
89 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83819108 |
90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83539848 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82865483 |
92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82449523 |
93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81453580 |
94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79291227 |
95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79261902 |
96 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.77298636 |
97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75913274 |
98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74075593 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73908525 |
100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72540501 |
101 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70127193 |
102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69507501 |
103 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68647230 |
104 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68019160 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66439625 |
106 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.65031738 |
107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64882440 |
108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.64333683 |
109 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.62216693 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.61524348 |
111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.60847929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.84366859 |
2 | MP0005671_abnormal_response_to | 3.74197597 |
3 | MP0001800_abnormal_humoral_immune | 3.39011987 |
4 | MP0001790_abnormal_immune_system | 3.35223240 |
5 | MP0005387_immune_system_phenotype | 3.35223240 |
6 | MP0005000_abnormal_immune_tolerance | 3.32082735 |
7 | MP0003436_decreased_susceptibility_to | 3.28410850 |
8 | MP0006082_CNS_inflammation | 3.20637530 |
9 | MP0003303_peritoneal_inflammation | 3.09147970 |
10 | MP0000685_abnormal_immune_system | 3.07472947 |
11 | MP0002452_abnormal_antigen_presenting | 3.05780817 |
12 | MP0009785_altered_susceptibility_to | 2.95712084 |
13 | MP0002723_abnormal_immune_serum | 2.89771757 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.82052220 |
15 | MP0005058_abnormal_lysosome_morphology | 2.81349588 |
16 | MP0002419_abnormal_innate_immunity | 2.80723493 |
17 | MP0002420_abnormal_adaptive_immunity | 2.77775919 |
18 | MP0001819_abnormal_immune_cell | 2.74984498 |
19 | MP0005025_abnormal_response_to | 2.74227729 |
20 | MP0003763_abnormal_thymus_physiology | 2.67928011 |
21 | MP0004510_myositis | 2.32810174 |
22 | MP0002398_abnormal_bone_marrow | 2.31146440 |
23 | MP0002405_respiratory_system_inflammati | 2.28140455 |
24 | MP0000716_abnormal_immune_system | 2.20894777 |
25 | MP0003300_gastrointestinal_ulcer | 2.10750424 |
26 | MP0009333_abnormal_splenocyte_physiolog | 2.09165996 |
27 | MP0003172_abnormal_lysosome_physiology | 2.09018789 |
28 | MP0000689_abnormal_spleen_morphology | 2.06521529 |
29 | MP0002166_altered_tumor_susceptibility | 2.04648053 |
30 | MP0005464_abnormal_platelet_physiology | 2.02792355 |
31 | MP0003724_increased_susceptibility_to | 1.93081514 |
32 | MP0002722_abnormal_immune_system | 1.89444945 |
33 | MP0001845_abnormal_inflammatory_respons | 1.88903438 |
34 | MP0004947_skin_inflammation | 1.86958092 |
35 | MP0002429_abnormal_blood_cell | 1.81804493 |
36 | MP0010155_abnormal_intestine_physiology | 1.78913569 |
37 | MP0001853_heart_inflammation | 1.71651193 |
38 | MP0005310_abnormal_salivary_gland | 1.71190242 |
39 | MP0001873_stomach_inflammation | 1.71075335 |
40 | MP0001533_abnormal_skeleton_physiology | 1.66644377 |
41 | MP0002006_tumorigenesis | 1.65744229 |
42 | MP0002933_joint_inflammation | 1.65741304 |
43 | MP0003448_altered_tumor_morphology | 1.52760262 |
44 | MP0000703_abnormal_thymus_morphology | 1.52640124 |
45 | MP0008469_abnormal_protein_level | 1.50256692 |
46 | MP0009840_abnormal_foam_cell | 1.47945822 |
47 | MP0005451_abnormal_body_composition | 1.43742823 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.35896045 |
49 | MP0003191_abnormal_cellular_cholesterol | 1.35119830 |
50 | MP0000858_altered_metastatic_potential | 1.34019020 |
51 | MP0002396_abnormal_hematopoietic_system | 1.30548231 |
52 | MP0000604_amyloidosis | 1.30538669 |
53 | MP0000343_altered_response_to | 1.29379501 |
54 | MP0003866_abnormal_defecation | 1.27562232 |
55 | MP0010307_abnormal_tumor_latency | 1.26348562 |
56 | MP0002998_abnormal_bone_remodeling | 1.18101036 |
57 | MP0005174_abnormal_tail_pigmentation | 1.13791304 |
58 | MP0000569_abnormal_digit_pigmentation | 1.08364514 |
59 | MP0005166_decreased_susceptibility_to | 1.03344683 |
60 | MP0004808_abnormal_hematopoietic_stem | 1.02216919 |
61 | MP0009764_decreased_sensitivity_to | 1.01956230 |
62 | MP0003183_abnormal_peptide_metabolism | 1.01258553 |
63 | MP0001851_eye_inflammation | 1.00304253 |
64 | MP0000490_abnormal_crypts_of | 0.98058015 |
65 | MP0003806_abnormal_nucleotide_metabolis | 0.97840823 |
66 | MP0003690_abnormal_glial_cell | 0.92465584 |
67 | MP0005397_hematopoietic_system_phenotyp | 0.91457981 |
68 | MP0001545_abnormal_hematopoietic_system | 0.91457981 |
69 | MP0000015_abnormal_ear_pigmentation | 0.88465305 |
70 | MP0002877_abnormal_melanocyte_morpholog | 0.85710182 |
71 | MP0009763_increased_sensitivity_to | 0.84039578 |
72 | MP0002139_abnormal_hepatobiliary_system | 0.82417733 |
73 | MP0002138_abnormal_hepatobiliary_system | 0.82015730 |
74 | MP0005076_abnormal_cell_differentiation | 0.81059004 |
75 | MP0002019_abnormal_tumor_incidence | 0.80989920 |
76 | MP0009278_abnormal_bone_marrow | 0.80716472 |
77 | MP0008260_abnormal_autophagy | 0.80187893 |
78 | MP0003075_altered_response_to | 0.79395898 |
79 | MP0004381_abnormal_hair_follicle | 0.75933775 |
80 | MP0002277_abnormal_respiratory_mucosa | 0.75723540 |
81 | MP0002132_abnormal_respiratory_system | 0.75597717 |
82 | MP0002136_abnormal_kidney_physiology | 0.74024212 |
83 | MP0003566_abnormal_cell_adhesion | 0.68242972 |
84 | MP0000249_abnormal_blood_vessel | 0.67053285 |
85 | MP0003795_abnormal_bone_structure | 0.66733118 |
86 | MP0004883_abnormal_blood_vessel | 0.65996253 |
87 | MP0003045_fibrosis | 0.64900905 |
88 | MP0005390_skeleton_phenotype | 0.64478321 |
89 | MP0005164_abnormal_response_to | 0.64131254 |
90 | MP0005167_abnormal_blood-brain_barrier | 0.63719417 |
91 | MP0003828_pulmonary_edema | 0.60802846 |
92 | MP0000609_abnormal_liver_physiology | 0.57841263 |
93 | MP0005023_abnormal_wound_healing | 0.56320227 |
94 | MP0001663_abnormal_digestive_system | 0.55772754 |
95 | MP0002254_reproductive_system_inflammat | 0.55110534 |
96 | MP0008057_abnormal_DNA_replication | 0.54760548 |
97 | MP0000371_diluted_coat_color | 0.54203239 |
98 | MP0008873_increased_physiological_sensi | 0.53284980 |
99 | MP0005075_abnormal_melanosome_morpholog | 0.53257020 |
100 | MP0002693_abnormal_pancreas_physiology | 0.52349355 |
101 | MP0008004_abnormal_stomach_pH | 0.51980643 |
102 | MP0003656_abnormal_erythrocyte_physiolo | 0.51919845 |
103 | MP0008874_decreased_physiological_sensi | 0.49743302 |
104 | MP0010352_gastrointestinal_tract_polyps | 0.48529933 |
105 | MP0002332_abnormal_exercise_endurance | 0.48074094 |
106 | MP0003091_abnormal_cell_migration | 0.47708529 |
107 | MP0000598_abnormal_liver_morphology | 0.47283370 |
108 | MP0000313_abnormal_cell_death | 0.45835339 |
109 | MP0003077_abnormal_cell_cycle | 0.45365709 |
110 | MP0008007_abnormal_cellular_replicative | 0.45075062 |
111 | MP0010094_abnormal_chromosome_stability | 0.44467992 |
112 | MP0002135_abnormal_kidney_morphology | 0.43450115 |
113 | MP0003453_abnormal_keratinocyte_physiol | 0.43099509 |
114 | MP0009765_abnormal_xenobiotic_induced | 0.42290181 |
115 | MP0000920_abnormal_myelination | 0.41504964 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.03256942 |
2 | Eczematoid dermatitis (HP:0000976) | 5.29534051 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.11612351 |
4 | Recurrent bronchitis (HP:0002837) | 4.34220185 |
5 | Myositis (HP:0100614) | 4.28698327 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.27532089 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.24980166 |
8 | Increased cerebral lipofuscin (HP:0011813) | 4.22466754 |
9 | Recurrent fungal infections (HP:0002841) | 4.08368769 |
10 | IgM deficiency (HP:0002850) | 3.93241438 |
11 | Autoimmune hemolytic anemia (HP:0001890) | 3.90493348 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.87392771 |
13 | Recurrent viral infections (HP:0004429) | 3.84568648 |
14 | Abnormality of macrophages (HP:0004311) | 3.83853247 |
15 | Systemic lupus erythematosus (HP:0002725) | 3.82080113 |
16 | Recurrent skin infections (HP:0001581) | 3.80671198 |
17 | Stomatitis (HP:0010280) | 3.78803260 |
18 | Abnormality of T cell number (HP:0011839) | 3.75721160 |
19 | T lymphocytopenia (HP:0005403) | 3.75648542 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.71993316 |
21 | Agammaglobulinemia (HP:0004432) | 3.67124924 |
22 | Obstructive lung disease (HP:0006536) | 3.65668650 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65668650 |
24 | Mediastinal lymphadenopathy (HP:0100721) | 3.65227720 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60560842 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60560842 |
27 | Autoimmune thrombocytopenia (HP:0001973) | 3.51203478 |
28 | Vasculitis (HP:0002633) | 3.50265814 |
29 | Orchitis (HP:0100796) | 3.45343402 |
30 | Retrobulbar optic neuritis (HP:0100654) | 3.43985121 |
31 | Optic neuritis (HP:0100653) | 3.43985121 |
32 | Meningitis (HP:0001287) | 3.43196454 |
33 | Chronic otitis media (HP:0000389) | 3.42925665 |
34 | Inflammation of the large intestine (HP:0002037) | 3.40019131 |
35 | Abnormality of T cells (HP:0002843) | 3.28500905 |
36 | Gastrointestinal inflammation (HP:0004386) | 3.23540916 |
37 | Pustule (HP:0200039) | 3.23478280 |
38 | Gastrointestinal stroma tumor (HP:0100723) | 3.21380509 |
39 | Cellulitis (HP:0100658) | 3.21328095 |
40 | Disinhibition (HP:0000734) | 3.20796841 |
41 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20343999 |
42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20343999 |
43 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20343999 |
44 | Dysostosis multiplex (HP:0000943) | 3.20087455 |
45 | IgG deficiency (HP:0004315) | 3.17321399 |
46 | Colitis (HP:0002583) | 3.16010421 |
47 | Gastrointestinal infarctions (HP:0005244) | 3.12627965 |
48 | Recurrent sinusitis (HP:0011108) | 3.11943683 |
49 | Gingivitis (HP:0000230) | 3.09305119 |
50 | Lymphopenia (HP:0001888) | 3.05599138 |
51 | Nasal polyposis (HP:0100582) | 3.02936864 |
52 | Severe combined immunodeficiency (HP:0004430) | 2.98936187 |
53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98244167 |
54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98017069 |
55 | Combined immunodeficiency (HP:0005387) | 2.96751879 |
56 | Thyroiditis (HP:0100646) | 2.88415441 |
57 | Panhypogammaglobulinemia (HP:0003139) | 2.87730060 |
58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.87375373 |
59 | Agnosia (HP:0010524) | 2.83552282 |
60 | Chronic diarrhea (HP:0002028) | 2.82281603 |
61 | Pulmonary infiltrates (HP:0002113) | 2.79444131 |
62 | Recurrent pneumonia (HP:0006532) | 2.78243142 |
63 | Abnormality of T cell physiology (HP:0011840) | 2.77590493 |
64 | IgA deficiency (HP:0002720) | 2.76094421 |
65 | Chest pain (HP:0100749) | 2.72287272 |
66 | Granulocytopenia (HP:0001913) | 2.69522883 |
67 | Leukocytosis (HP:0001974) | 2.67810280 |
68 | Basal ganglia calcification (HP:0002135) | 2.64249285 |
69 | Recurrent lower respiratory tract infections (HP:0002783) | 2.64174933 |
70 | Osteomyelitis (HP:0002754) | 2.63697567 |
71 | Glomerulonephritis (HP:0000099) | 2.63189495 |
72 | Abnormality of the nasal mucosa (HP:0000433) | 2.54070361 |
73 | Emphysema (HP:0002097) | 2.50089498 |
74 | Petechiae (HP:0000967) | 2.47846526 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47652451 |
76 | Mucopolysacchariduria (HP:0008155) | 2.47652451 |
77 | Spontaneous hematomas (HP:0007420) | 2.46066473 |
78 | Keratoconjunctivitis (HP:0001096) | 2.45663807 |
79 | Bronchitis (HP:0012387) | 2.43542566 |
80 | Increased IgM level (HP:0003496) | 2.43253634 |
81 | Arterial thrombosis (HP:0004420) | 2.41358478 |
82 | Loss of speech (HP:0002371) | 2.41274231 |
83 | Gangrene (HP:0100758) | 2.40578956 |
84 | Chronic sinusitis (HP:0011109) | 2.39331232 |
85 | Abnormality of eosinophils (HP:0001879) | 2.39279441 |
86 | Encephalitis (HP:0002383) | 2.37134942 |
87 | Axonal loss (HP:0003447) | 2.34009157 |
88 | Abnormality of the prostate (HP:0008775) | 2.33891785 |
89 | Eosinophilia (HP:0001880) | 2.32135979 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31656350 |
91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31656350 |
92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31656350 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.31517331 |
94 | Pulmonary embolism (HP:0002204) | 2.31345551 |
95 | Interstitial pulmonary disease (HP:0006530) | 2.30475033 |
96 | Hypergammaglobulinemia (HP:0010702) | 2.29888348 |
97 | Hepatosplenomegaly (HP:0001433) | 2.27125318 |
98 | Polyneuropathy (HP:0001271) | 2.26482012 |
99 | Hemoptysis (HP:0002105) | 2.26407858 |
100 | Abnormality of B cell number (HP:0010975) | 2.26170533 |
101 | B lymphocytopenia (HP:0010976) | 2.26170533 |
102 | Periodontitis (HP:0000704) | 2.25833402 |
103 | Abnormality of the pleura (HP:0002103) | 2.25729073 |
104 | Verrucae (HP:0200043) | 2.24465840 |
105 | Papilloma (HP:0012740) | 2.24465840 |
106 | Myocardial infarction (HP:0001658) | 2.24024194 |
107 | Lymphoma (HP:0002665) | 2.20919163 |
108 | Joint swelling (HP:0001386) | 2.20904192 |
109 | Restrictive lung disease (HP:0002091) | 2.20461031 |
110 | Urticaria (HP:0001025) | 2.20191072 |
111 | Increased IgE level (HP:0003212) | 2.19292559 |
112 | Glomerulopathy (HP:0100820) | 2.13651478 |
113 | Epistaxis (HP:0000421) | 2.12611048 |
114 | Pulmonary fibrosis (HP:0002206) | 2.12608085 |
115 | Skin rash (HP:0000988) | 2.09474721 |
116 | Amaurosis fugax (HP:0100576) | 2.08852320 |
117 | Increased serum ferritin (HP:0003281) | 2.06415498 |
118 | Premature loss of primary teeth (HP:0006323) | 2.05482094 |
119 | Arthralgia (HP:0002829) | 2.05149012 |
120 | Sepsis (HP:0100806) | 2.04185714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.32172208 |
2 | TXK | 3.69395096 |
3 | BLK | 3.58706694 |
4 | TYK2 | 3.23964845 |
5 | KIT | 2.88168681 |
6 | MAP3K14 | 2.79703211 |
7 | TBK1 | 2.72283766 |
8 | ZAP70 | 2.63957368 |
9 | PRPF4B | 2.34282618 |
10 | IKBKE | 2.31637004 |
11 | JAK1 | 2.28391314 |
12 | SYK | 2.23253259 |
13 | ITK | 2.22261921 |
14 | IRAK4 | 2.20034109 |
15 | JAK3 | 2.18204148 |
16 | CSF1R | 2.10252967 |
17 | RIPK4 | 1.97371896 |
18 | IRAK3 | 1.95539651 |
19 | STK10 | 1.94891173 |
20 | TESK2 | 1.83254792 |
21 | GRK6 | 1.80584655 |
22 | BTK | 1.78270284 |
23 | IKBKB | 1.77725564 |
24 | ERN1 | 1.75561637 |
25 | LCK | 1.69134476 |
26 | TGFBR2 | 1.66474152 |
27 | BMPR2 | 1.64960297 |
28 | CSK | 1.62386766 |
29 | HCK | 1.62331732 |
30 | TEC | 1.57288049 |
31 | NME2 | 1.48862123 |
32 | FGFR4 | 1.44801914 |
33 | FES | 1.39904319 |
34 | MST4 | 1.38988501 |
35 | * LYN | 1.35885058 |
36 | TAOK3 | 1.28680774 |
37 | TAOK2 | 1.28235587 |
38 | MAP3K13 | 1.25867210 |
39 | NEK9 | 1.18551932 |
40 | FGFR3 | 1.16478844 |
41 | LRRK2 | 1.12366808 |
42 | CLK1 | 1.12081049 |
43 | SCYL2 | 1.07977929 |
44 | KDR | 1.06713496 |
45 | PIM1 | 1.02087309 |
46 | JAK2 | 0.95267124 |
47 | PKN2 | 0.94870159 |
48 | PRKCQ | 0.94760903 |
49 | PIM2 | 0.93258777 |
50 | RPS6KA4 | 0.92391854 |
51 | MAP2K3 | 0.90955360 |
52 | MAP3K10 | 0.90226027 |
53 | PRKCH | 0.90044404 |
54 | CHUK | 0.89835949 |
55 | TESK1 | 0.86418602 |
56 | SIK2 | 0.83624452 |
57 | CAMKK2 | 0.83322931 |
58 | TAOK1 | 0.79068495 |
59 | EPHB1 | 0.77772706 |
60 | MOS | 0.76283130 |
61 | MARK3 | 0.74696495 |
62 | PIK3CG | 0.72048658 |
63 | CDC42BPA | 0.65887478 |
64 | TRIB3 | 0.65325331 |
65 | MAP3K1 | 0.64344589 |
66 | FGR | 0.63364057 |
67 | PASK | 0.62337361 |
68 | MAPK7 | 0.60385886 |
69 | PRKCD | 0.59158165 |
70 | NLK | 0.58782642 |
71 | EIF2AK3 | 0.56972952 |
72 | MAP3K12 | 0.54912378 |
73 | GRK7 | 0.54177374 |
74 | STK4 | 0.52030854 |
75 | PDK1 | 0.51571267 |
76 | DDR2 | 0.51553867 |
77 | TNK2 | 0.51481614 |
78 | ABL1 | 0.50988384 |
79 | ADRBK2 | 0.49433928 |
80 | EGFR | 0.47220988 |
81 | EEF2K | 0.45565641 |
82 | CDK6 | 0.45340148 |
83 | CAMKK1 | 0.44484778 |
84 | PAK4 | 0.44337080 |
85 | TTN | 0.42610743 |
86 | IRAK1 | 0.42474647 |
87 | MAPK12 | 0.42109716 |
88 | CDK12 | 0.41929508 |
89 | * FYN | 0.41833969 |
90 | ARAF | 0.40998891 |
91 | RIPK1 | 0.40316028 |
92 | EIF2AK1 | 0.39514009 |
93 | CDK4 | 0.38171638 |
94 | MAPK4 | 0.38162392 |
95 | MAPKAPK2 | 0.37036865 |
96 | NEK2 | 0.35759627 |
97 | MATK | 0.35748684 |
98 | INSR | 0.35515861 |
99 | PDPK1 | 0.34654104 |
100 | CAMK1D | 0.34388686 |
101 | SMG1 | 0.32568161 |
102 | ALK | 0.29507163 |
103 | PBK | 0.28304971 |
104 | MAP2K6 | 0.28110551 |
105 | RPS6KC1 | 0.27960812 |
106 | RPS6KL1 | 0.27960812 |
107 | PTK6 | 0.26269165 |
108 | MAP3K11 | 0.25705752 |
109 | MAP3K3 | 0.25641127 |
110 | STK24 | 0.25244859 |
111 | MAP3K8 | 0.23561267 |
112 | PRKD2 | 0.23358334 |
113 | TRPM7 | 0.23343078 |
114 | RPS6KA6 | 0.22809834 |
115 | PDGFRB | 0.22767677 |
116 | SIK3 | 0.22742525 |
117 | EPHA3 | 0.22714028 |
118 | EIF2AK2 | 0.21686297 |
119 | KSR2 | 0.21157902 |
120 | MAP3K5 | 0.20824312 |
121 | MELK | 0.20365122 |
122 | RPS6KA5 | 0.20350746 |
123 | * IGF1R | 0.19251100 |
124 | MAPK11 | 0.18389538 |
125 | HIPK2 | 0.17505139 |
126 | TLK1 | 0.15295888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.94101501 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81396900 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.80006746 |
4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.78775104 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.65673639 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61411025 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59763666 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57483091 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55846248 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.52626749 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49722169 |
12 | Measles_Homo sapiens_hsa05162 | 2.41431909 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.34146658 |
14 | Lysosome_Homo sapiens_hsa04142 | 2.20650837 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.14988381 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12270394 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04316421 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02841460 |
19 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00220039 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.86768401 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72892807 |
22 | Asthma_Homo sapiens_hsa05310 | 1.65782084 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62709756 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61726249 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.56280343 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.54850774 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49221762 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46553035 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46225847 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45281757 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.41238097 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.41084822 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40845689 |
34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40819703 |
35 | Malaria_Homo sapiens_hsa05144 | 1.40018043 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.39898510 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39036172 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38714856 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35993930 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30295456 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.28055568 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25115256 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.17043113 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11644811 |
45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11037895 |
46 | Hepatitis B_Homo sapiens_hsa05161 | 1.10087155 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06643459 |
48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96188025 |
49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96102187 |
50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93511907 |
51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89014303 |
52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83494352 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81039348 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.78348811 |
55 | DNA replication_Homo sapiens_hsa03030 | 0.75553972 |
56 | Base excision repair_Homo sapiens_hsa03410 | 0.72628781 |
57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71590426 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.71331424 |
59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71310384 |
60 | Endocytosis_Homo sapiens_hsa04144 | 0.69060259 |
61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66641219 |
62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64765539 |
63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61430057 |
64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58846025 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58663466 |
66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57421260 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56832120 |
68 | Mismatch repair_Homo sapiens_hsa03430 | 0.53418385 |
69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46899207 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45119038 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44841681 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44470840 |
73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43380170 |
74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42778269 |
75 | Proteasome_Homo sapiens_hsa03050 | 0.42449236 |
76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41937593 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39477273 |
78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38484196 |
79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38042459 |
80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36557518 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35657420 |
82 | Bladder cancer_Homo sapiens_hsa05219 | 0.34213847 |
83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33995097 |
84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33580542 |
85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33159218 |
86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31063031 |
87 | Homologous recombination_Homo sapiens_hsa03440 | 0.30657145 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30096527 |
89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29464861 |
90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26914618 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25858099 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23719254 |
93 | Amoebiasis_Homo sapiens_hsa05146 | 0.23464115 |
94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22952045 |
95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20103069 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18525578 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18377597 |
98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17925244 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16539662 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.16285466 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16280680 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13669370 |
103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.13518982 |
104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12784212 |
105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12415556 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12300244 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.11953575 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10619120 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10087978 |
110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09392410 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07529306 |
112 | Prostate cancer_Homo sapiens_hsa05215 | 0.07286659 |
113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.03088737 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.02431323 |
115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.01833480 |
116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.00789153 |